Clinical trial

Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder…

NCT00285818 · Stanford University, Other · Completed

Key facts

NCT number NCT00285818
Title Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECT
Official title A Double-blind, Placebo-controlled Study of Mifepristone in Patients With Non-psychotic Major Depressive Disorder Referred for Bilateral Electroconvulsive Therapy (ECT)
Lead sponsor Stanford University, Other
Status Completed
Study type Interventional
Conditions Depression
Intervention type Drug
Interventions Mifepristone, Placebo Oral Capsule
Enrollment 11
Start date Jan 1, 2003
Primary completion Jan 1, 2009
Completion Apr 1, 2009
First posted Feb 2, 2006
Last update posted Feb 16, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies